About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Yale Cancer Center
https://www.yalecancercenter.org/
ASCO® 2024
Yale Cancer Answers
ASH CME Series
Smilow Shares with Primary Care
Grand Rounds
Head and Neck
Leukemia
Myeloma
Benign Hematology
MDS and MPN
Skin
GYN
Supportive & Palliative Care
GU
Breast
CNS
GI
General Oncology
Lymphoma
Brain
Lung
Business
Head and Neck
Gynecologic
Benign Hematology
Breast
GI
Lung
GU
Hematologic Oncology
Brain
Cancer Screening
DEI (Diversity, Equity and Inclusion)
2021 ASH Highlights
General Events
Yale Liver Cancer Symposium 2019
Yale Cancer Center Immuno-Oncology Symposium 2019
2018 Yale Pancreas Symposium
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Case-Based Discussions in Lymphoma: 1L MCL, CD30+ T-Cell, and R/R CLL
By
Yale Cancer Center
FEATURING
Scott Huntington
,
Shalin Kothari
,
Tarsheen Sethi
By
Yale Cancer Center
FEATURING
Scott Huntington
,
Shalin Kothari
,
Tarsheen Sethi
65 views
May 14, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
03:38
Lilly Medical Affairs
SERDS: Relevance and Role in Current & Future Treatments for HR+…
Feat.
K. Jhaveri
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
ASH CME Series
14:34
Yale Cancer Center
Yale Cancer Center Allogeneic Stem Cell Transplantation Updates
Feat.
L. Bachegowda
14:59
Yale Cancer Center
Advances in CAR-Ts in Myeloma: Recent Research & Clinical Findin…
Feat.
N. Bar
16:44
Yale Cancer Center
Summary of Promising Recent Studies in LR-MDS, HR-MDS, and R/R AML
Feat.
R. Shallis
34:25
Yale Cancer Center
Splicing Factor Mutations in MDS: Role in Disease Biology and Potent…
Feat.
S. Halene
22:16
Yale Cancer Center
Updates on Cellular Therapy Advances in Lymphoma
Feat.
I. Isufi
18:19
Yale Cancer Center
Summary of Recent Advances in Adult ALL
Feat.
L. Mendez
05:32
Yale Cancer Center
Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…
Feat.
J. Ryu
14:24
Yale Cancer Center
Cancer-Associated VTE: Dynamic Modelling and Prediction With DNA Liq…
Feat.
A. Pine
24:12
Yale Cancer Center
Latest Advances in HL and PTCL Treatments
Feat.
T. Sethi
14:35
Yale Cancer Center
Case-Based Discussions in Lymphoma: 1L MCL, CD30+ T-Cell, and R/R CLL
Feat.
S. Huntington,
S. Kothari,
T. Sethi
19:56
Yale Cancer Center
Frontline Treatment Strategies in MM: A Comprehensive Overview of Cl…
Feat.
T. Parker
12:49
Yale Cancer Center
Emerging Therapies in MF & PV: Insights From Recent Clinical Tri…
Feat.
J. Bewersdorf
13:31
Yale Cancer Center
BTKi Rilzabrutinib in Patients With Relapsed ITP
Feat.
E. Chang
05:02
Yale Cancer Center
Latest Trial Results for Recombinant ADAMTS13 in cTTP
Feat.
J. Ryu
26:25
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL…
Feat.
S. Kothari
33:21
Yale Cancer Center
Review of CAR T-Cell Therapies
Feat.
I. Isufi
24:04
Yale Cancer Center
Updates on Allogeneic Stem Cell Transplant
Feat.
L. Bachegowda
21:17
Yale Cancer Center
ASH 2022 Highlights: Follicular and Indolent NHL
Feat.
F. Montanari
22:32
Yale Cancer Center
Updates From ASH 2022 for LBCL and MCL
Feat.
S. Kothari
12:55
Yale Cancer Center
ASH 2022 Highlights: T-Cell Lymphoma and Hodgkin Lymphoma
Feat.
T. Sethi
17:49
Yale Cancer Center
Yale ASH Highlights - Myeloid Malignancies: Focus on MPNs
Feat.
N. Podoltsev
19:57
Yale Cancer Center
Yale Cancer Center Selected Updates in MDS
Feat.
A. Zeidan
11:22
Yale Cancer Center
Yale ASH Highlights: AML Updates
Feat.
L. Mendez
07:48
Yale Cancer Center
Yale ASH 2022 Highlights: ALL Updates
Feat.
L. Mendez
04:47
Yale Cancer Center
Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: …
Feat.
L. Van Doren
06:33
Yale Cancer Center
Yale ASH Updates on Sickle Cell Disease: Impact of Hydroxyurea and V…
Feat.
L. Van Doren
12:34
Yale Cancer Center
Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …
Feat.
G. Goshua
13:17
Yale Cancer Center
Yale ASH Updates on Thrombosis: Apixaban for Central Venous Catheter…
Feat.
A. Sharda
25:34
Yale Cancer Center
Newly Diagnosed Myeloma: A Focus on Subgroups at ASH 2022
Feat.
N. Bar
27:10
Yale Cancer Center
Highlights in R/R Myeloma and AL Amyloidosis From ASH 2022
Feat.
S. Browning
